Steven E Patterson - Publications

University of Minnesota, Twin Cities, Minneapolis, MN 
Medicinal Chemistry

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pogula PK, De Chatterjee A, Chi M, VanKoten HW, Das S, Patterson SE. Triazoxins: Novel nucleosides with anti-Giardia activity. Bioorganic & Medicinal Chemistry Letters. 127175. PMID 32327222 DOI: 10.1016/j.bmcl.2020.127175  1
2019 McDaniel YZ, Patterson SE, Mansky LM. Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis. Antiviral Research. 104540. PMID 31247245 DOI: 10.1016/j.antiviral.2019.104540  1
2018 Qiu L, Patterson SE, Bonnac LF, Geraghty RJ. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis. Plos Neglected Tropical Diseases. 12: e0006421. PMID 29672522 DOI: 10.1371/journal.pntd.0006421  1
2017 Summerhill EM, Gumpert E, Hoyle GW, Jordt SE, Jugg BJ, Martin JG, Matalon S, Patterson SE, Prezant DJ, Sciuto AM, Svendsen ER, White CW, Veress L. An Official American Thoracic Society Workshop Report: Chemical Inhalational Disasters: Biology of Lung Injury, Development of Novel Therapeutics, and Medical Preparedness. Annals of the American Thoracic Society. PMID 28418689 DOI: 10.1513/AnnalsATS.201704-297WS  0.04
2017 Moeller BM, Crankshaw DL, Briggs J, Nagasawa H, Patterson SE. In-Vitro Mercaptopyruvate Sulfurtransferase Species Comparison in Humans and Common Laboratory Animals. Toxicology Letters. PMID 28412453 DOI: 10.1016/j.toxlet.2017.04.005  1
2016 Patterson SE, Moeller B, Nagasawa HT, Vince R, Crankshaw DL, Briggs J, Stutelberg MW, Vinnakota CV, Logue BA. Development of sulfanegen for mass cyanide casualties. Annals of the New York Academy of Sciences. PMID 27308865 DOI: 10.1111/nyas.13114  1
2016 Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & Medicinal Chemistry. PMID 27117260 DOI: 10.1016/j.bmc.2016.03.052  1
2016 Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM. Dual anti-HIV mechanism of clofarabine. Retrovirology. 13: 20. PMID 27009333 DOI: 10.1186/s12977-016-0254-0  1
2016 Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. 5-azacytidine enhances the mutagenesis of HIV-1 by reduction to 5-aza-2'-deoxycytidine. Antimicrobial Agents and Chemotherapy. PMID 26833151 DOI: 10.1128/AAC.03084-15  1
2015 Stutelberg MW, Dzisam JK, Monteil AR, Petrikovics I, Boss GR, Patterson SE, Rockwood GA, Logue BA. Simultaneous determination of 3-mercaptopyruvate and cobinamide in plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1008: 181-188. PMID 26655110 DOI: 10.1016/j.jchromb.2015.11.027  1
2015 Rawson JM, Landman SR, Reilly CS, Bonnac L, Patterson SE, Mansky LM. Lack of Mutational Hot Spots during Decitabine-Mediated HIV-1 Mutagenesis. Antimicrobial Agents and Chemotherapy. 59: 6834-43. PMID 26282416 DOI: 10.1128/AAC.01644-15  1
2014 Beach LB, Rawson JM, Kim B, Patterson SE, Mansky LM. Novel inhibitors of human immunodeficiency virus type 2 infectivity. The Journal of General Virology. 95: 2778-83. PMID 25103850 DOI: 10.1099/vir.0.069864-0  1
2014 Lee J, Kim JG, Mahon SB, Mukai D, Yoon D, Boss GR, Patterson SE, Rockwood G, Isom G, Brenner M. Noninvasive optical cytochrome c oxidase redox state measurements using diffuse optical spectroscopy. Journal of Biomedical Optics. 19: 055001. PMID 24788369 DOI: 10.1117/1.JBO.19.5.055001  1
2014 Stutelberg MW, Vinnakota CV, Mitchell BL, Monteil AR, Patterson SE, Logue BA. Determination of 3-mercaptopyruvate in rabbit plasma by high performance liquid chromatography tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 949: 94-8. PMID 24480329 DOI: 10.1016/j.jchromb.2014.01.006  1
2014 Dapp MJ, Bonnac L, Patterson SE, Mansky LM. Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63. PMID 24155391 DOI: 10.1128/JVI.02444-13  1
2014 Clouser CL, Bonnac L, Mansky LM, Patterson SE. Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs. Antiviral Chemistry & Chemotherapy. 23: 223-30. PMID 23994876 DOI: 10.3851/IMP2682  1
2013 Rawson JM, Heineman RH, Beach LB, Martin JL, Schnettler EK, Dapp MJ, Patterson SE, Mansky LM. 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorganic & Medicinal Chemistry. 21: 7222-8. PMID 24120088 DOI: 10.1016/j.bmc.2013.08.023  1
2013 Bonnac LF, Mansky LM, Patterson SE. Structure-activity relationships and design of viral mutagens and application to lethal mutagenesis. Journal of Medicinal Chemistry. 56: 9403-14. PMID 23914828 DOI: 10.1021/jm400653j  1
2013 Patterson SE, Monteil AR, Cohen JF, Crankshaw DL, Vince R, Nagasawa HT. Cyanide antidotes for mass casualties: water-soluble salts of the dithiane (sulfanegen) from 3-mercaptopyruvate for intramuscular administration. Journal of Medicinal Chemistry. 56: 1346-9. PMID 23301495 DOI: 10.1021/jm301633x  1
2013 Dapp MJ, Patterson SE, Mansky LM. Back to the future: revisiting HIV-1 lethal mutagenesis. Trends in Microbiology. 21: 56-62. PMID 23195922 DOI: 10.1016/j.tim.2012.10.006  1
2012 Kim JG, Lee J, Mahon SB, Mukai D, Patterson SE, Boss GR, Tromberg BJ, Brenner M. Noninvasive monitoring of treatment response in a rabbit cyanide toxicity model reveals differences in brain and muscle metabolism. Journal of Biomedical Optics. 17: 105005. PMID 23223999 DOI: 10.1117/1.JBO.17.10.105005  1
2012 Smith SE, Bida AT, Davis TR, Sicotte H, Patterson SE, Gil D, Schrum AG. IP-FCM measures physiologic protein-protein interactions modulated by signal transduction and small-molecule drug inhibition. Plos One. 7: e45722. PMID 23029201 DOI: 10.1371/journal.pone.0045722  1
2012 Clouser CL, Chauhan J, Bess MA, van Oploo JL, Zhou D, Dimick-Gray S, Mansky LM, Patterson SE. Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine. Bioorganic & Medicinal Chemistry Letters. 22: 6642-6. PMID 23010273 DOI: 10.1016/j.bmcl.2012.08.108  1
2012 Belani KG, Singh H, Beebe DS, George P, Patterson SE, Nagasawa HT, Vince R. Cyanide toxicity in juvenile pigs and its reversal by a new prodrug, sulfanegen sodium. Anesthesia and Analgesia. 114: 956-61. PMID 22392971 DOI: 10.1213/ANE.0b013e31824c4eb5  1
2012 Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, O'Sullivan MG, Patterson SE, Mansky LM. Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1. Antimicrobial Agents and Chemotherapy. 56: 1942-8. PMID 22271861 DOI: 10.1128/AAC.06161-11  1
2012 Greggs WM, Clouser CL, Patterson SE, Mansky LM. Discovery of drugs that possess activity against feline leukemia virus. The Journal of General Virology. 93: 900-5. PMID 22258856 DOI: 10.1099/vir.0.039909-0  1
2011 Chan A, Crankshaw DL, Monteil A, Patterson SE, Nagasawa HT, Briggs JE, Kozocas JA, Mahon SB, Brenner M, Pilz RB, Bigby TD, Boss GR. The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning. Clinical Toxicology (Philadelphia, Pa.). 49: 366-73. PMID 21740135 DOI: 10.3109/15563650.2011.584879  1
2011 Greggs WM, Clouser CL, Patterson SE, Mansky LM. Broadening the use of antiretroviral therapy: the case for feline leukemia virus. Therapeutics and Clinical Risk Management. 7: 115-22. PMID 21479142 DOI: 10.2147/TCRM.S17731  1
2011 Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, Chauhan J, VanHoutan IM, Patterson SE, Mansky LM. Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine. Plos One. 6: e15840. PMID 21264291 DOI: 10.1371/journal.pone.0015840  1
2010 Staake M, Chauhan J, Zhou D, Shanker A, De Chatterjee A, Das S, Patterson SE. Phosphonoxins III: synthesis of α-aminophosphonate analogs of antifungal polyoxins with anti-Giardia activity. Organic Letters. 12: 4596-9. PMID 20857975 DOI: 10.1021/ol101913t  1
2010 Brenner M, Kim JG, Lee J, Mahon SB, Lemor D, Ahdout R, Boss GR, Blackledge W, Jann L, Nagasawa HT, Patterson SE. Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicity. Toxicology and Applied Pharmacology. 248: 269-76. PMID 20705081 DOI: 10.1016/j.taap.2010.08.002  1
2010 Clouser CL, Patterson SE, Mansky LM. Exploiting drug repositioning for discovery of a novel HIV combination therapy. Journal of Virology. 84: 9301-9. PMID 20610712 DOI: 10.1128/JVI.01006-10  1
2008 Zhou D, Staake M, Patterson SE. Phosphonoxins II: Diastereoselective synthesis of phosphonic acid analogues of polyoxins Organic Letters. 10: 2179-2182. PMID 18447364 DOI: 10.1021/ol800552k  1
2007 Bonnac LF, Gao GY, Chen L, Patterson SE, Jayaram HN, Pankiewicz KW. Efficient synthesis of benzamide riboside, a potential anticancer agent. Nucleosides, Nucleotides & Nucleic Acids. 26: 1249-53. PMID 18066762 DOI: 10.1080/15257770701528222  1
2007 Nagasawa HT, Goon DJ, Crankshaw DL, Vince R, Patterson SE. Novel, orally effective cyanide antidotes. Journal of Medicinal Chemistry. 50: 6462-4. PMID 18038966 DOI: 10.1021/jm7011497  1
2007 Crankshaw DL, Goon DJW, Briggs JE, DeLong D, Kuskowski M, Patterson SE, Nagasawa HT. A novel paradigm for assessing efficacies of potential antidotes against neurotoxins in mice Toxicology Letters. 175: 111-117. PMID 18024011 DOI: 10.1016/j.toxlet.2007.10.001  1
2007 Chen L, Gao G, Felczak K, Bonnac L, Patterson SE, Wilson D, Bennett EM, Jayaram HN, Hedstrom L, Pankiewicz KW. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues. Journal of Medicinal Chemistry. 50: 5743-51. PMID 17958343 DOI: 10.1021/jm070568j  1
2007 Suk DH, Rejman D, Dykstra CC, Pohl R, Pankiewicz KW, Patterson SE. Phosphonoxins: rational design and discovery of a potent nucleotide anti-Giardia agent. Bioorganic & Medicinal Chemistry Letters. 17: 2811-6. PMID 17360182 DOI: 10.1016/j.bmcl.2007.02.063  1
2007 Suk DH, Bonnac L, Dykstra CC, Pankiewicz KW, Patterson SE. Rational design and synthesis of novel nucleotide anti-Giardia agents. Bioorganic & Medicinal Chemistry Letters. 17: 2064-7. PMID 17258459 DOI: 10.1016/j.bmcl.2007.01.014  1
2007 Bonnac L, Chen L, Pathak R, Gao G, Ming Q, Bennett E, Felczak K, Kullberg M, Patterson SE, Mazzola F, Magni G, Pankiewicz KW. Probing binding requirements of NAD kinase with modified substrate (NAD) analogues. Bioorganic & Medicinal Chemistry Letters. 17: 1512-5. PMID 17258457 DOI: 10.1016/j.bmcl.2007.01.012  1
2007 Paliakov E, Henary M, Say M, Patterson SE, Parker A, Manzel L, Macfarlane DE, Bojarski AJ, Strekowski L. Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides Bioorganic and Medicinal Chemistry. 15: 324-332. PMID 17049254 DOI: 10.1016/j.bmc.2006.09.059  1
2006 Pankiewicz KW, Gao G, Patterson SE. Synthesis of methylenebis(phosphonate) analogs of dinucleotide pyrophosphates Current Protocols in Nucleic Acid Chemistry / Edited by Serge L. Beaucage ... [Et Al.]. PMID 18428948  1
2006 Chen L, Rejman D, Bonnac L, Pankiewicz KW, Patterson SE. Nucleoside-5'-phosphoimidazolides: reagents for facile synthesis of dinucleoside pyrophosphates. Current Protocols in Nucleic Acid Chemistry / Edited by Serge L. Beaucage ... [Et Al.]. Unit 13.4. PMID 18428947 DOI: 10.1002/0471142700.nc1304s23  1
2006 Rejman D, Olesiak M, Chen L, Patterson SE, Wilson D, Jayaram HN, Hedstrom L, Pankiewicz KW. Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase. Journal of Medicinal Chemistry. 49: 5018-22. PMID 16884314 DOI: 10.1021/jm060479r  1
2005 Wang P, Hollecker L, Pankiewicz KW, Patterson SE, Whitaker T, McBrayer TR, Tharnish PM, Stuyver LJ, Schinazi RF, Otto MJ, Watanabe KA. Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one and its 3'-deoxysugar analogue as potential anti-hepatitis C virus agents. Nucleosides, Nucleotides & Nucleic Acids. 24: 957-60. PMID 16248071 DOI: 10.1081/NCN-200059314  1
2005 Shi J, Du J, Ma T, Pankiewicz KW, Patterson SE, Hassan AE, Tharnish PM, McBrayer TR, Lostia S, Stuyver LJ, Watanabe KA, Chu CK, Schinazi RF, Otto MJ. Synthesis and in vitro anti-HCV activity of beta-D- and 1-2'-deoxy-2'-fluororibonucleosides. Nucleosides, Nucleotides & Nucleic Acids. 24: 875-9. PMID 16248053 DOI: 10.1081/NCN-200059224  1
2005 Clark JL, Hollecker L, Mason JC, Stuyver LJ, Tharnish PM, Lostia S, McBrayer TR, Schinazi RF, Watanabe KA, Otto MJ, Furman PA, Stec WJ, Patterson SE, Pankiewicz KW. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. Journal of Medicinal Chemistry. 48: 5504-8. PMID 16107149 DOI: 10.1021/jm0502788  1
2005 Shi J, Du J, Ma T, Pankiewicz KW, Patterson SE, Tharnish PM, McBrayer TR, Stuyver LJ, Otto MJ, Chu CK, Schinazi RF, Watanabe KA. Synthesis and anti-viral activity of a series of d- and l-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon system. Bioorganic & Medicinal Chemistry. 13: 1641-52. PMID 15698782 DOI: 10.1016/j.bmc.2004.12.011  1
2004 Strekowski L, Parker AN, Hojjat M, Say M, Zegrocka-Stendel O, Patterson SE, Tanious FA, Wilson WD. Triple-helix DNA selective 2-(2-naphthyl)quinoline intercalators. Acta Poloniae Pharmaceutica. 61: 70-2. PMID 15909945  1
2004 Wang P, Hollecker L, Pankiewicz KW, Patterson SE, Whitaker T, McBrayer TR, Tharnish PM, Sidwell RW, Stuyver LJ, Otto MJ, Schinazi RF, Watanabe KA. Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity. Journal of Medicinal Chemistry. 47: 6100-3. PMID 15537363 DOI: 10.1021/jm0401210  1
2004 Pankiewicz KW, Patterson SE, Black PL, Jayaram HN, Risal D, Goldstein BM, Stuyver LJ, Schinazi RF. Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target. Current Medicinal Chemistry. 11: 887-900. PMID 15083807 DOI: 10.2174/0929867043455648  1
2002 Stuyver LJ, Lostia S, Patterson SE, Clark JL, Watanabe KA, Otto MJ, Pankiewicz KW. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents. Antiviral Chemistry & Chemotherapy. 13: 345-52. PMID 12718406  1
2002 Yalowitz JA, Pankiewicz K, Patterson SE, Jayaram HN. Cytotoxicity and cellular differentiation activity of methylenebis(phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell lines. Cancer Letters. 181: 31-8. PMID 12430176 DOI: 10.1016/S0304-3835(02)00045-9  1
2002 Pankiewicz KW, Lesiak-Watanabe KB, Watanabe KA, Patterson SE, Jayaram HN, Yalowitz JA, Miller MD, Seidman M, Majumdar A, Prehna G, Goldstein BM. Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia. Journal of Medicinal Chemistry. 45: 703-12. PMID 11806722 DOI: 10.1021/jm0104116  1
Show low-probability matches.